PRLD icon

Prelude Therapeutics

39 hedge funds and large institutions have $994M invested in Prelude Therapeutics in 2020 Q3 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
+39
Holders Change %
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
39
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
TD Asset Management
26
TD Asset Management
Ontario, Canada
$678K +$678K +22,509 New
Norges Bank
27
Norges Bank
Norway
$603K +$603K +20,000 New
Wellington Management Group
28
Wellington Management Group
Massachusetts
$503K +$503K +16,703 New
Morgan Stanley
29
Morgan Stanley
New York
$396K +$396K +13,155 New
MS
30
Maven Securities
Jersey
$264K +$264K +9,091 New
Jane Street
31
Jane Street
New York
$222K +$222K +7,375 New
ECM
32
ExodusPoint Capital Management
New York
$214K +$214K +7,108 New
PHK
33
Point72 Hong Kong
Hong Kong
$188K +$188K +6,251 New
PVI
34
Pura Vida Investments
New York
$151K +$151K +5,000 New
UBS Group
35
UBS Group
Switzerland
$43K +$43K +1,423 New
JCM
36
Jacobi Capital Management
Pennsylvania
$15K +$15K +500 New
Millennium Management
37
Millennium Management
New York
$5.71K +$5.71K +189,573 New
CSS
38
Cubist Systematic Strategies
Connecticut
$3K +$3K +100 New